– the leading provider of online annual reports to individual and institutional investors.

Protalix BioTherapeutics, Inc.

Protalix BioTherapeutics, Inc., a biopharmaceutical company, through Protalix Ltd., focuses on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx protein expression system in the United States.

No investor fact sheets added yet
No responsibility reports added yet

Browse Reports